DIA Bioventure Day

Is the current Bioventure paradigm delivering return for patients and investors? This is the key question to be addressed by stakeholders from the funding, and from the innovating side.

Back to Agenda

Session 2: Innovative Funding Models

Speaker(s)

Ritchie Head

Ceratium Limited, United Kingdom

Director

Funding Private and Public Enterprises

Joep Muijrers

PureTech Health, United States

Chief Financial Officer

The German Stock Exchange Venture Network

Oliver Mahr

Deutsche Boerse Venture Network, Germany

Investment & Fintech Hub Manager

Megafunds: Concept Introduction & Discussion

Dimitrios Athanasiou, MBA

WORLD DUCHENNE ORGANIZATION (WDO) , MDA HELLAS, Greece

Patient Advocate

Have an account?